InvestSMART

Archer Materials Limited (ASX:AXE)

ALERT: Price-sensitive ASX Announcement for AXE
Current share price for AXE : $0.365 -0.025 (-6.41%)+
Announcement
Release
29 Jan 2026 9:22AM
Price at Release
$0.390
Full Release
download
Summary
Archer Materials Limited reported its quarterly activities and Appendix 4C cash flow for the period ending 31 December 2025. The company made significant advancements in its 12CQ and Biochip programs, including progress in quantum state readout for carbon qubit materials and achieving room temperature spin lifetimes. Archer signed collaboration agreements with Emergence Quantum and CSIRO to enhance quantum technology applications. The Biochip project, in partnership with IMEC, met clinical standards for blood potassium testing on a silicon platform, which could streamline supply chains and reduce costs. Financially, Archer ended the quarter with a cash balance of $10.3 million, not including a $2.1 million R&D tax rebate, and reported no debt. The report also highlighted a change in the board with Andrew Just joining as a Non-Executive Director.
Key Points
  • Improved quantum state readout for Archer’s carbon qubit materials.
  • Signed a collaboration agreement with Emergence Quantum.
  • Agreement with CSIRO to develop quantum machine learning models.
  • Biochip met clinical standards for blood potassium testing.
  • End of quarter cash balance of $10.3 million, with no debt.
  • Appointment of Andrew Just as Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.